Main Library
A session at the Association of Community Cancer Centers (ACCC) 48th Annual Meeting and Cancer Center Business Summit brought together industry experts to discuss innovations and obstacles in precision medicine and value-based payment in oncology.
The panel participants included Alexis Finkelberg Bortniker, JD, Partner, Foley & Lardner; Ira Klein, MD, MBA, FACP, Vice President, Medical Affairs & Payer Relations, Tempus Labs; Deirdre Saulet, PhD, Expert Partner, Advisory Board Company; James Hamrick, MD, MPH, Vice President, Clinical Oncology, Flatiron Health; and Nate Walcker, MBA, Chief Executive Officer, Florida Cancer Specialists & Research Institute.
“Value may be one of the most overused words in health care,” said Dr Saulet, explaining that the definition of value varies significantly. When defining value, Dr Saulet believes patients and patient-centered care should be at the forefront.